BeStock  
Stocks › Biotechnology › EWTX

Edgewise Therapeutics EWTX

US equityMarket cap rank #2154Biotechnology
$39.91 −$1.27 (-3.07%)
Market closed · Nov 22, 5:10 am ET · Last extended-hours $39.91 0.00%
Open$40.81
Prev close$41.17
Day range$39.71 – $41.41
Volume1.19M
Market cap$4.37B
P/E (TTM)4.8
Dividend yield–

Analyst view

ConsensusBuy
Analysts10
Average target$58.88+47.6% vs. price
  • Buy 100%
Low $51.00Now $39.91Avg $58.88High $85.00

Recent rating changes

The last 20 actions on file set price targets from $51.00 to $85.00, averaging $57.11.

DateFirmRatingTarget
9 Nov 2026 H.C. Wainwright BUY $57.00
6 Nov 2026 Piper Sandler BUY $51.00
6 Nov 2026 Wedbush BUY $51.00
5 Nov 2026 Raymond James BUY $85.00
5 Nov 2026 Wedbush BUY $51.00
5 Nov 2026 Evercore BUY $55.00
5 Nov 2026 H.C. Wainwright BUY $57.00
5 Nov 2026 RBC Capital BUY $59.00
27 Oct 2026 RBC Capital BUY $59.00
15 Oct 2026 William Blair BUY $53.00
14 Oct 2026 H.C. Wainwright BUY $57.00
13 Oct 2026 Piper Sandler BUY $51.00
8 Oct 2026 H.C. Wainwright BUY $57.00
23 Sep 2026 Truist Financial BUY –
23 Sep 2026 Wedbush BUY $53.00
23 Sep 2026 Leerink Partners BUY –
23 Sep 2026 H.C. Wainwright BUY $57.00
22 Sep 2026 RBC Capital BUY $59.00
21 Sep 2026 H.C. Wainwright BUY $57.00
1 Sep 2026 RBC Capital BUY $59.00

Discussion

No comments yet — be the first to weigh in on EWTX.

Sign in to join the discussion.

Scroll to Top